Abstract
Breast cancer is a disease of unknown etiology, whose major risk factors are genetic alterations. Polymorphism of the calcium-sensing receptor (CaSR) has been a focus of some recent studies, due to a probable association with breast cancer risk and tumor aggressiveness. A relationship between polymorphic rs17251221 variant of the CaSR gene, and allele G (considered a gain-of-function mutation) and breast cancer risk has been stressed, despite the paucity of studies found in the literature. The present study involved 137 women (69 women with breast cancer—case; and 68 controls without breast cancer) who had 3 ml of peripheral blood drawn for DNA study. Genomic DNA was extracted from leukocytes by genoty** technique with real-time polymerase chain reaction. The AG genotype (rs17251221) was present in 13 women (18.84%) from the case group and in 8 (11.76%) women from the control group (p = 0.3434), while the GG genotype (rs17251221) did not occur in any group. In contrast, no statistically significant difference was observed between the AG genotype of variant rs17251221 in premenopausal case and control women (p = 0.71). There was also no statistically significant difference between postmenopausal case and control patients (p = 0.6851). In the current study, CaSR gene polymorphism of SNP variant rs17251221 did not show any statistically significant association with breast cancer, in both premenopausal and postmenopausal women.
Similar content being viewed by others
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
Chattopadhyay S, Siddiqui S, Akhtar MS, Najm MZ, Deo SVS, Shukla NK, et al. Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case–control study from North India. Tumor Biol. 2014;35(5):4517–27.
National Institute of Cancer (INCA). Estimating cancer in Brazil. 2016. http://www.inca.gov.br/estimativa/2016/.
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 1997;71(5):800–9.
Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, et al. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121(2):269–75.
Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, et al. Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review. Onco Targets Ther. 2016;9:655–69.
Li X, Konga X, Jianga L, Maa T, Yanb S, Yuanb C. A genetic polymorphism (rs17251221) in the calcium-sensing receptors associated with breast cancer susceptibility and prognosis. Cell Physiol Biochem. 2014;33:165–72.
Magno AL, Wardbk BK, Ratajczak T. The calcium-sensing receptor: a molecular perspective. Endocr Rev. 2011;32(1):3–30.
Kim W, Wysolmerski JJ. Calcium-sensing receptor in breast physiology and cancer. Front Physiol. 2016;30(7):440.
Zhang C, Miller CL, Brown EM, Yang JJ. The calcium sensing receptor: from calcium sensing to signaling. Sci China Life Sci. 2015;58(1):14–27.
Cheng I, Klingensmith ME, Chattopadhyay N, Kifor O, Butters RR, Soybel DI, et al. Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metabol. 1998;83(2):703–7.
Tennakoon S, Aggarwal A, Kállay E. The calcium-sensing receptor and the hallmarks of cancer. Biochim Biophys Acta. 2016;1863(6):1398–407.
López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Puente XS, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7(1):162.
Neves-Manta FS, Pereira R, Vianna R, de Araújo ARB, Gitaí DLG, da Silva DA, et al. Revisiting the genetic ancestry of Brazilians using autosomal AIM-Indels. PLoS ONE. 2013;8(9):75145.
Amador MA, Cavalcante GC, Santos NP, Gusmão L, Guerreiro JF, Ribeiro-dos-Santos Â, et al. Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations. BMC Res Notes. 2016;16(9):101.
Wang L, Widatalla SE, Whalen DS, Ochieng J, Sakwe AM. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients. BMC Cancer. 2017;17:511.
Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, et al. Ambrosone. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium. Int J Cancer. 2016;138(9):118–2126.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Committee of the Federal University of Piauí (Teresina, Brazil; Approval No. 43447015.8.0000). The entire research was in compliance with the terms of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Campos-Verdes, L.M., da Silva-Sampaio, J.P., Costa-Silva, D.R. et al. Genetic polymorphism of calcium-sensing receptor in women with breast cancer. Med Oncol 35, 23 (2018). https://doi.org/10.1007/s12032-018-1089-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-018-1089-4